Yep, here is the news...
Company Press Release
Insider Buys National Boston Medical Stock
National Boston Medical Announces New Investor Relations Firm
TAUNTON, Mass.--(BUSINESS WIRE)--Nov. 12, 1998--National Boston Medical Inc. (OTC BB:NBMXD - news; ''the company'') announced Thursday, pursuant to disclosure requirements under the Securities Acts, that a Medical Advisory Board member of the company has increased their position from 5% to 6.7% of the common shares of stock, becoming the single largest shareholder in National Boston Medical Inc.
Dan Hoyng, CEO of National Boston Medical said, ''It is encouraging to see that members of the Medical Advisory Board are committed to our vision for engineering healthcare for tomorrow.''
National Boston Medical Inc. further announced that it has signed a one-year contract with Liberty Capital Group Inc. of Bellingham, Wash. for financial and public relations services.
Liberty Capital is a full service Public, Investor and Media relations firm that specializes in publicly traded companies and financial services. Liberty Capital will be the sole contact for all shareholders, potential investors, media and institutional contacts for National Boston.
About the new IR company, Daniel Hoyng, president and CEO of National Boston Medical, stated: ''Our company has been working diligently to provide investors value and high returns. The appointment of Liberty Capital Group Inc. is a strong step toward this goal. Liberty has proven its abilities through its track record, making us confident that they will be a tremendous asset to National Boston's team.''
J. Allen Greig, president of Liberty Capital was quoted as saying: ''We are very excited about our new role with National Boston Medical. We feel this company has great potential and we are eager to help them begin to exploit their new prospects for bringing value to their shareholders.''
National Boston Medical Inc. distributes, manufactures and designs infection-reducing medical and dental instruments and personal care products engineered to enhance public health and hygiene.
For further information, please contact the following departments at Liberty Capital Group: 1-360-676-8072 or visit Liberty Capital's web site at www.libertycap.com.
Investor Relations: Tom Raack, Ext. 1008 Media Relations: Peter Wort, Ext. 1003
Mike Glick (Newsletters), Ext. 1002
Except for the historical information presented herein, the matters set forth in this press release are forward looking statements within the meaning of the ''safe-harbor'' provision of the Private Securities Litigation Reform Act of 1995. These forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These forward-looking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements.
----------------------------------------------------------------------
Contact:
National Boston Medical Inc., Taunton
Daniel Hoyng, 800/807-2259
508/880-5208 (fax)
or
Liberty Capital Group Inc., Bellingham, Wash.
Tom Raack, 360/676-8072, Ext. 1008
360/676-9493 (fax)
Hey, the Baron is GONE ;)
|
